title: Rocuronium vs. succinylcholine in the emergency department: a critical appraisal.
abstract: BACKGROUND
  Two methods of paralysis are available for rapid sequence intubation (RSI) in the emergency department (ED): depolarizing agents such as succinylcholine, and non-depolarizing drugs such as rocuronium. Rocuronium is a useful alternative when succinylcholine is contraindicated. Contraindications to succinylcholine include allergy, history of malignant hyperthermia, denervation syndromes, and patients who are 24-48 h post burn or crush injury. Non-depolarizing drugs have the advantage of causing less pain due to post-paralysis myalgias.
  
  
  OBJECTIVE
  Can rocuronium replace succinylcholine as the paralytic of choice for RSI in the ED?
  
  
  METHODS
  Four relevant studies were selected from an evidence search and a structured review performed.
  
  
  RESULTS
  For the outcomes of clinically acceptable intubation conditions and time to onset, the two agents were not statistically significantly different. Succinylcholine seems to produce conditions that have higher satisfaction scores.
  
  
  CONCLUSIONS
  Succinylcholine remains the drug of choice for ED RSI unless there is a contraindication to its usage.
authors.affiliation: Department of Emergency Medicine, Los Angeles County/University of Southern California Medical Center, Los Angeles, California, USA.
authors.forename: William K
authors.initials: WK
authors.lastname: Mallon
authors.forename: Samuel M
authors.initials: SM
authors.lastname: Keim
authors.forename: Jan M
authors.initials: JM
authors.lastname: Shoenberger
authors.forename: Ron M
authors.initials: RM
authors.lastname: Walls
mesh_terms: D000328:Adult; D000732:Androstanols / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007442:Intubation, Intratracheal / Q000379:methods*; D008297:Male; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology / Q000627:therapeutic use*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000077123:Rocuronium; D013390:Succinylcholine / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000732:Androstanols; D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine; D000077123:Rocuronium